Viking Therapeutics (VKTX) Misses Q2 EPS by 13c
Get Alerts VKTX Hot Sheet
Join SI Premium – FREE
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Arrowhead Pharma (ARWR) at Buy
- Penguin Solutions plans $650M convertible notes offering due 2031
- Sanuwave Q2 2026 revenue tops revised guidance range
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share